S. De Sanjose

National Cancer Institute Division of Cancer Epidemiology and Genetics
Dr. Silvia de Sanjosé is an MD, PhD with over 30 years of expertise in the epidemiology of HPV and related cancers. She served as the President of the International Papillomavirus Society during 2015-2018 and has been Co-Chair of the Cape Town, Sydney, and Barcelona (virtual) conferences of the IPVS. She has experience in large international studies involving HPV worldwide genotyping and has been involved in the development of HPV based screening guidelines for cervical cancer in Spain and in Catalonia. She has previously worked at the International Agency for Research on Cancer, and at the Catalan Institute of Oncology. Currently serving as Consultant for US NCI. Dr. de Sanjosé leads teams working to evaluate the use of artificial intelligence applied to cervical images. She is also involved in studies providing an insight on the association between HPV and HIV in cervical carcinogenesis applied to screening strategies. She is an affiliated professor at the Department of Epidemiology, University of Washington.

Author Of 15 Presentations

DIAGNOSTIC ACCURACY OF CERVICAL CANCER SCREENING STRATEGIES FOR CIN2+ AMONG WOMEN LIVING WITH HIV: A SYSTEMATIC REVIEW AND META-ANALYSIS (ID 617)

Presenter
Lecture Time
02:01 PM - 02:13 PM

ADOPTING DEEP-LEARNING BASED "AUTOMATED VISUAL EVALUATION" FOR CERVICAL SCREENING AS A CLINICAL TEST: CAUTIONS IN INTERPRETING THE OUTPUT (ID 440)

Presenter
Lecture Time
06:35 AM - 06:40 AM

MODEL VALIDATION OF TEST SENSITIVITY OF VISUAL INSPECTION WITH ACETIC ACID (VIA) AGAINST LONGITUDINAL TRIALS IN INDIA (ID 296)

Presenter
Lecture Time
07:25 AM - 07:30 AM

Call to action (ID 907)

Presenter
Lecture Time
01:32 PM - 01:47 PM

HPV16-D IS THE MOST AGGRESSIVE VARIANT AND COULD BE ASSOCIATED WITH SHORTER TIME OF VULVAR CANCER PROGRESSION FROM VIN (ID 506)

Presenter
Lecture Time
06:20 AM - 06:25 AM

BENEFITS AND HARMS OF CERVICAL SCREENING IN HIV POSITIVE WOMEN: AN ANALYSIS TO INFORM UPDATED CERVICAL CANCER SCREENING GUIDELINES FOR WOMEN LIVING WITH HIV (ID 311)

Presenter
Lecture Time
02:25 PM - 02:37 PM

Next steps: Field evaluation and expected outcomes and closing remarks (ID 1082)

Presenter
Lecture Time
07:45 AM - 08:00 AM

MONTH 24 IMMUNOGENICITY AND SAFETY OF 1, 2 AND 3 DOSES OF GARDASIL-9® AND CERVARIX® IN TANZANIAN GIRLS AGED 9-14Y: THE DORIS RANDOMISED TRIAL (ID 593)

Presenter
Lecture Time
12:01 PM - 12:13 PM

PREVALENCE AND DETERMINANTS OF HUMAN PAPILLOMAVIRUS IN TRANSGENDER WOMEN AND MALE SEX WORKERS IN CATALONIA: SEXCOHORT STUDY (ID 435)

Presenter
Lecture Time
06:20 AM - 06:25 AM

Updates in the epidemiology of cervical cancer and pre-cancer (ID 729)

Presenter
Lecture Time
12:02 PM - 12:18 PM

MONITORING CERVICAL CANCER SCREENING WORLDWIDE: PROGRAMMES AND AGE-SPECIFIC COVERAGE ESTIMATES FOR 202 COUNTRIES AND TERRITORIES (ID 504)

Presenter
Lecture Time
11:46 AM - 11:58 AM

BENEFITS, HARMS AND COST-EFFECTIVENESS OF CERVICAL SCREENING IN 78 LOW-INCOME AND LOWER-MIDDLE INCOME COUNTRIES: MODELLING TO SUPPORT WHO 2021 CERVICAL SCREENING GUIDELINES (ID 301)

Presenter
Lecture Time
06:13 PM - 06:25 PM

CERVICAL CANCER SCREENING COVERAGE ESTIMATES IN THE AMERICAS REGION, 2019 (ID 920)

Presenter
Lecture Time
06:27 PM - 06:39 PM

REDESIGN OF A RAPID LOW-COST EXTENDED HPV GENOTYPING ASSAY FOR CERVICAL SCREENING (ID 530)

Presenter
Lecture Time
06:10 AM - 06:15 AM

BENEFITS, HARMS AND COST-EFFECTIVENESS OF HPV-MRNA TESTING IN 78 LOW-INCOME AND LOWER-MIDDLE INCOME COUNTRIES: MODELLING TO SUPPORT WHO 2021 CERVICAL SCREENING GUIDELINES (ID 334)

Presenter
Lecture Time
12:22 PM - 12:34 PM

Presenter of 3 Presentations

Updates in the epidemiology of cervical cancer and pre-cancer (ID 729)

Presenter
Lecture Time
12:02 PM - 12:18 PM

Next steps: Field evaluation and expected outcomes and closing remarks (ID 1082)

Presenter
Lecture Time
07:45 AM - 08:00 AM

Call to action (ID 907)

Presenter
Lecture Time
01:32 PM - 01:47 PM

Moderator of 4 Sessions

Session Type
Workshop
Date
Mon, Nov 15, 2021
Session Time
10:00 AM - 11:30 AM
Session Icon
Live
Session Type
Workshop
Date
Mon, Nov 15, 2021
Session Time
12:00 PM - 01:30 PM
Session Icon
Live
Session Type
Special Interest Satellite Symposium
Date
Tue, Nov 16, 2021
Session Time
06:00 AM - 11:00 PM
Session Icon
Pre-Recorded
Session Type
Public Health Oral
Date
Wed, Nov 17, 2021
Session Time
10:00 AM - 11:00 AM
Session Icon
Pre-Recorded with Live Q&A

Poster Author Of 6 e-Posters

HIGH SENSITIVITY DETECTION OF ENDOMETRIAL CANCER-ASSOCIATED GENETIC VARIANTS IN MINIMALLY-INVASIVE GYNECOLOGICAL SAMPLES (ID 513)

Presenter
My link to connect
https://teams.microsoft.com/l/meetup-join/19%3ameeting_ZTI0ZDc3NmItNjA0Ni00ODAyLTk2ZjctNDYxMTU3MTA3ZGI4%40thread.v2/0?context=%7b%22Tid%22%3a%223b9427dc-d30e-43bc-8c06-ff7253676fec%22%2c%22Oid%22%3a%220fd90268-1369-4b1f-a067-1d8fd01a7764%22%7d
Availability
15-19 November from 11.00 AM - 12.00 AM (GMT+1:00)